These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 15176475)
21. Tropisetron improves deficient inhibitory auditory processing in DBA/2 mice: role of alpha 7 nicotinic acetylcholine receptors. Hashimoto K; Iyo M; Freedman R; Stevens KE Psychopharmacology (Berl); 2005 Nov; 183(1):13-9. PubMed ID: 16136299 [TBL] [Abstract][Full Text] [Related]
22. Translational utility of rodent hippocampal auditory gating in schizophrenia research: a review and evaluation. Smucny J; Stevens KE; Olincy A; Tregellas JR Transl Psychiatry; 2015 Jun; 5(6):e587. PubMed ID: 26101850 [TBL] [Abstract][Full Text] [Related]
23. Delayed emergence of behavioral and electrophysiological effects following juvenile ketamine exposure in mice. Nagy LR; Featherstone RE; Hahn CG; Siegel SJ Transl Psychiatry; 2015 Sep; 5(9):e635. PubMed ID: 26371763 [TBL] [Abstract][Full Text] [Related]
24. Mice expressing constitutively active Gsalpha exhibit stimulus encoding deficits similar to those observed in schizophrenia patients. Maxwell CR; Liang Y; Kelly MP; Kanes SJ; Abel T; Siegel SJ Neuroscience; 2006 Sep; 141(3):1257-64. PubMed ID: 16750890 [TBL] [Abstract][Full Text] [Related]
25. Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia. Umbricht D; Schmid L; Koller R; Vollenweider FX; Hell D; Javitt DC Arch Gen Psychiatry; 2000 Dec; 57(12):1139-47. PubMed ID: 11115327 [TBL] [Abstract][Full Text] [Related]
26. The effects of low dose ketamine on sensory gating, neuroendocrine secretion and behavior in healthy human subjects. van Berckel BN; Oranje B; van Ree JM; Verbaten MN; Kahn RS Psychopharmacology (Berl); 1998 Jun; 137(3):271-81. PubMed ID: 9683005 [TBL] [Abstract][Full Text] [Related]
27. Differential effects of traxoprodil and S-ketamine on quantitative EEG and auditory event-related potentials as translational biomarkers in preclinical trials in rats and mice. Raith H; Schuelert N; Duveau V; Roucard C; Plano A; Dorner-Ciossek C; Ferger B Neuropharmacology; 2020 Jul; 171():108072. PubMed ID: 32243874 [TBL] [Abstract][Full Text] [Related]
29. [Glutaminergic hypothesis of schizophrenia: clinical research studies with ketamine]. Mechri A; Saoud M; Khiari G; d'Amato T; Dalery J; Gaha L Encephale; 2001; 27(1):53-9. PubMed ID: 11294039 [TBL] [Abstract][Full Text] [Related]
30. Chronic ketamine impairs fear conditioning and produces long-lasting reductions in auditory evoked potentials. Amann LC; Halene TB; Ehrlichman RS; Luminais SN; Ma N; Abel T; Siegel SJ Neurobiol Dis; 2009 Aug; 35(2):311-7. PubMed ID: 19467327 [TBL] [Abstract][Full Text] [Related]
31. The effects of ketamine on the mismatch negativity (MMN) in humans - A meta-analysis. Rosburg T; Kreitschmann-Andermahr I Clin Neurophysiol; 2016 Feb; 127(2):1387-1394. PubMed ID: 26699665 [TBL] [Abstract][Full Text] [Related]
32. Brown Norway rats, a putative schizophrenia model, show increased electroencephalographic activity at rest and decreased event-related potential amplitude, power, and coherence in the auditory sensory gating paradigm. Tomimatsu Y; Hibino R; Ohta H Schizophr Res; 2015 Aug; 166(1-3):171-7. PubMed ID: 26004687 [TBL] [Abstract][Full Text] [Related]
33. Dopaminergic modulation of the P50 auditory-evoked potential in a computer model of the CA3 region of the hippocampus: its relationship to sensory gating in schizophrenia. Moxon KA; Gerhardt GA; Adler LE Biol Cybern; 2003 Apr; 88(4):265-75. PubMed ID: 12690485 [TBL] [Abstract][Full Text] [Related]
34. Ketamine administration during the second postnatal week induces enduring schizophrenia-like behavioral symptoms and reduces parvalbumin expression in the medial prefrontal cortex of adult mice. Jeevakumar V; Driskill C; Paine A; Sobhanian M; Vakil H; Morris B; Ramos J; Kroener S Behav Brain Res; 2015 Apr; 282():165-75. PubMed ID: 25591475 [TBL] [Abstract][Full Text] [Related]
35. Neuronal injury, but not microglia activation, is associated with ketamine-induced experimental schizophrenic model in mice. Hou Y; Zhang H; Xie G; Cao X; Zhao Y; Liu Y; Mao Z; Yang J; Wu C Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():107-16. PubMed ID: 23603358 [TBL] [Abstract][Full Text] [Related]
36. Hypericum extract reverses S-ketamine-induced changes in auditory evoked potentials in humans - possible implications for the treatment of schizophrenia. Murck H; Spitznagel H; Ploch M; Seibel K; Schaffler K Biol Psychiatry; 2006 Mar; 59(5):440-5. PubMed ID: 16165104 [TBL] [Abstract][Full Text] [Related]
38. Prelimbic NMDA receptors stimulation mimics the attenuating effects of clozapine on the auditory electrophysiological rebound induced by ketamine withdrawal. Incrocci RM; Paliarin F; Nobre MJ Neurotoxicology; 2018 Dec; 69():1-10. PubMed ID: 30170016 [TBL] [Abstract][Full Text] [Related]
39. N-methyl-D-aspartate receptor in working memory impairments in schizophrenia: event-related potential study of late stage of working memory process. Ahn KH; Youn T; Cho SS; Ha TH; Ha KS; Kim MS; Kwon JS Prog Neuropsychopharmacol Biol Psychiatry; 2003 Sep; 27(6):993-9. PubMed ID: 14499316 [TBL] [Abstract][Full Text] [Related]
40. Antipsychotic-like properties of phosphodiesterase 4 inhibitors: evaluation of 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone (RO-20-1724) with auditory event-related potentials and prepulse inhibition of startle. Halene TB; Siegel SJ J Pharmacol Exp Ther; 2008 Jul; 326(1):230-9. PubMed ID: 18420599 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]